Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response

Adaptive immune responses protect against infection with dengue virus (DENV), yet cross-reactivity with distinct serotypes can precipitate life-threatening clinical disease. We found that clonotypes expressing the T cell antigen receptor (TCR) β-chain variable region 11 (TRBV11-2) were 'prefere...

ver descrição completa

Detalhes bibliográficos
Principais autores: Culshaw, A, Ladell, K, Gras, S, McLaren, J, Miners, K, Farenc, C, van den Heuvel, H, Gostick, E, Dejnirattisai, W, Wangteeraprasert, A, Duangchinda, T, Chotiyarnwong, P, Limpitikul, W, Vasanawathana, S, Malasit, P, Dong, T, Rossjohn, J, Mongkolsapaya, J, Price, D, Screaton, G
Formato: Journal article
Idioma:English
Publicado em: Springer Nature 2017
Descrição
Resumo:Adaptive immune responses protect against infection with dengue virus (DENV), yet cross-reactivity with distinct serotypes can precipitate life-threatening clinical disease. We found that clonotypes expressing the T cell antigen receptor (TCR) β-chain variable region 11 (TRBV11-2) were 'preferentially' activated and mobilized within immunodominant human-leukocyte-antigen-(HLA)-A*11:01-restricted CD8+ T cell populations specific for variants of the nonstructural protein epitope NS3133 that characterize the serotypes DENV1, DENV3 and DENV4. In contrast, the NS3133-DENV2-specific repertoire was largely devoid of such TCRs. Structural analysis of a representative TRBV11-2+ TCR demonstrated that cross-serotype reactivity was governed by unique interplay between the variable antigenic determinant and germline-encoded residues in the second β-chain complementarity-determining region (CDR2β). Extensive mutagenesis studies of three distinct TRBV11-2+ TCRs further confirmed that antigen recognition was dependent on key contacts between the serotype-defined peptide and discrete residues in the CDR2β loop. Collectively, these data reveal an innate-like mode of epitope recognition with potential implications for the outcome of sequential exposure to heterologous DENVs.